EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review

Max Hoebink, Thomas A H Steunenberg, Sjoerd Smit, Henrike M Hamer, Arno M Wiersema, Kak Khee Yeung, Vincent Jongkind

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2026.03.017 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Max Hoebink und 6 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC location Vrije Universiteit, department of Vascular Surgery, Amsterdam, Netherlands; Dijklander Ziekenhuis, Department of Vascular Surg…. Hauptthemen laut MEDLINE: Anticoagulants, Drug Monitoring, Factor Xa Inhibitors, Heparin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anti-Xa test is regarded as the standard assay to measure unfractionated heparin activity in a laboratory setting, but its use during arterial procedures has not been established. The objectives of this systematic review, designed as a scoping review, were to structure the existing body of evidence, identify possible research gaps, and provide guidance for future research on the applicability of anti-Xa to measure the heparin activity during arterial procedures. Literature search resulted in 55 included reports (cardiac procedures: 44 reports; noncardiac procedures: 9 reports; cardiac and noncardiac procedures: 2 reports). During arterial procedures, anti-Xa is widely used as reference laboratory test to validate heparin point-of-care assays, compare different heparinization strategies and measure residual heparin activity at the end of the procedure or after heparin reversal using protamine. There is considerable heterogeneity among included reports, which hampers the ability to draw firm conclusions. The available literature is insufficient to define optimal periprocedural heparin activity measured by anti-Xa. Currently, anti-Xa is not used as a primary heparin monitoring assay during arterial procedures. The impact of alterations in periprocedural anti-Xa activity on clinical outcomes has been rarely investigated. Anti-Xa measurements appear to be reproducible compared with point-of-care heparin activity essays but require standardization. In conclusion, anti-Xa is useful as a reference test to evaluate point-of-care heparin testing and compare heparin strategies during arterial procedures, but there is a high need for studies to investigate correlation of anti-Xa levels with clinical outcomes and to determine optimal anti-Xa levels for arterial procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsDrug MonitoringFactor Xa InhibitorsHeparinVascular Surgical ProceduresHumansArteriesBlood CoagulationPredictive Value of TestsReproducibility of Results

Stichwörter der Autor:innen

anti-Xacardiac surgical proceduresheparinscoping reviewvascular surgical procedures

Substanzen

AnticoagulantsFactor Xa InhibitorsHeparin

Autor:innen und Institutionen

  • Amsterdam UMC location Vrije Universiteit, department of Vascular Surgery, Amsterdam, Netherlands; Dijklander Ziekenhuis, Department of Vascular Surgery, Hoorn, Netherlands; Amsterdam Cardiovascular Sciences, Atheroscle…
  • Amsterdam UMC location Vrije Universiteit, department of Vascular Surgery, Amsterdam, Netherlands.
  • Amsterdam UMC location AMC, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam, Netherlands.
  • Amsterdam UMC location Vrije Universiteit, department of Vascular Surgery, Amsterdam, Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis and Aortic Diseases, Amsterdam, Netherlands.

Förderung

  • ZonMw
  • Medtronic

Zitieren

APA

Hoebink, M., Steunenberg, T. A. H., Smit, S., Hamer, H. M., Wiersema, A. M., Yeung, K. K., & Jongkind, V. (2026). Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.03.017

Vancouver

Hoebink M, Steunenberg TAH, Smit S, Hamer HM, Wiersema AM, Yeung KK, et al. Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.03.017

BibTeX
@article{Hoebink2026,
  author = {Hoebink, Max and Steunenberg, Thomas A H and Smit, Sjoerd and Hamer, Henrike M and Wiersema, Arno M and Yeung, Kak Khee and Jongkind, Vincent},
  title = {Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2026.03.017}
}
Kostenlos starten →